An Audit to Evaluate the Clinical Safety and PSA Response of Firmagon® (Degarelix) in Patients with Advanced Metastatic Prostate Cancer -. (2013). Journal of Cancer Research Updates, 2(1),  21-25. https://doi.org/10.6000/1929-2279.2013.02.01.4